Estradiol BenzoateCAS# 50-50-0 |
- Catalpol
Catalog No.:BCN5094
CAS No.:2415-24-9
- 2-Methoxyestradiol (2-MeOE2)
Catalog No.:BCC2228
CAS No.:362-07-2
- Estradiol Benzoate
Catalog No.:BCC4779
CAS No.:50-50-0
- Ethinyl Estradiol
Catalog No.:BCC3777
CAS No.:57-63-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 50-50-0 | SDF | Download SDF |
| PubChem ID | 222757 | Appearance | Powder |
| Formula | C25H28O3 | M.Wt | 376.49 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Ethanol : 0.25 mg/mL (0.62 mM; Need ultrasonic and warming) H2O : < 0.1 mg/mL (insoluble) DMSO : < 1 mg/mL (insoluble or slightly soluble) | ||
| Chemical Name | [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] benzoate | ||
| SMILES | CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5 | ||
| Standard InChIKey | UYIFTLBWAOGQBI-BZDYCCQFSA-N | ||
| Standard InChI | InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Estradiol Benzoate Dilution Calculator
Estradiol Benzoate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.6561 mL | 13.2806 mL | 26.5611 mL | 53.1223 mL | 66.4028 mL |
| 5 mM | 0.5312 mL | 2.6561 mL | 5.3122 mL | 10.6245 mL | 13.2806 mL |
| 10 mM | 0.2656 mL | 1.3281 mL | 2.6561 mL | 5.3122 mL | 6.6403 mL |
| 50 mM | 0.0531 mL | 0.2656 mL | 0.5312 mL | 1.0624 mL | 1.3281 mL |
| 100 mM | 0.0266 mL | 0.1328 mL | 0.2656 mL | 0.5312 mL | 0.664 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Estradiol benzoate is an estradiol analog which binds to the human, murine and chicken ERα with IC50 of 22-28 nM.
- Mercaptopurine (6-MP)
Catalog No.:BCC1186
CAS No.:50-44-2
- Clomiphene citrate
Catalog No.:BCC4480
CAS No.:50-41-9
- Cocaine
Catalog No.:BCN1901
CAS No.:50-36-2
- Thalidomide
Catalog No.:BCC2248
CAS No.:50-35-1
- Phenylbutazone
Catalog No.:BCC4822
CAS No.:50-33-9
- beta-Estradiol
Catalog No.:BCN2194
CAS No.:50-28-2
- Estriol
Catalog No.:BCN2235
CAS No.:50-27-1
- Prednisolone
Catalog No.:BCC4830
CAS No.:50-24-8
- Hydrocortisone
Catalog No.:BCN2192
CAS No.:50-23-7
- Corticosterone
Catalog No.:BCN2203
CAS No.:50-22-6
- Cyclophosphamide
Catalog No.:BCC1185
CAS No.:50-18-0
- Ergocalciferol
Catalog No.:BCN2208
CAS No.:50-14-6
- Reserpine
Catalog No.:BCN4960
CAS No.:50-55-5
- Oxytocin
Catalog No.:BCC5435
CAS No.:50-56-6
- Chloroquine diphosphate
Catalog No.:BCC3915
CAS No.:50-63-5
- Niclosamide
Catalog No.:BCC5081
CAS No.:50-65-7
- 5-Hydroxytryptamine
Catalog No.:BCC9204
CAS No.:50-67-9
- 1,3:2,4-Di-p-methylbenyliedene sorbitol
Catalog No.:BCC4847
CAS No.:54686-97-4
- Actinomycin D
Catalog No.:BCC2385
CAS No.:50-76-0
- Aspirin (Acetylsalicylic acid)
Catalog No.:BCC2097
CAS No.:50-78-2
- Ascorbic acid
Catalog No.:BCN2207
CAS No.:50-81-7
- Thymidine
Catalog No.:BCN5622
CAS No.:50-89-5
- Floxuridine
Catalog No.:BCC1187
CAS No.:50-91-9
- Ephedrine Hydrochloride
Catalog No.:BCC8322
CAS No.:50-98-6
Incorporation of estradiol benzoate to CIDR protocol improves the reproductive responses in crossbred dairy heifers.[Pubmed:27913974]
Trop Anim Health Prod. 2017 Feb;49(2):347-351.
The present study was designed to determine the effect of Estradiol Benzoate (EB) on reproductive response following a controlled internal drug release (CIDR) protocol in crossbred (Sahiwal x Friesian) dairy heifers. In the first trial, a total of 100 crossbred dairy heifers were treated with CIDR protocol for 7 days and injected with the PGF2alpha on day 6. After 24 h of CIDR removal, one group (EB = 50) was injected with Estradiol Benzoate whereas the other (control = 50) remained untreated. Estrus intensity and response were recorded visually and ovulation rate was recorded by ultrasonography. All heifers were artificially inseminated at 48 and 60 h following CIDR removal. Heifers were scanned for pregnancy within days 30-40 of artificial insemination (AI). In the second trial, two subgroups of heifers were included to observe the estrus and ovulatory events. The results of the first trial revealed that estrus response was achieved 100% in both the treatment groups. Estrus intensity (2.9 +/- 0.1 vs. 2.0 +/- 0.7) and ovulation rate (100 vs. 88%) differed significantly (P < 0.05) between the EB and control groups. However, a tendency for higher pregnancy per AI was observed (54 vs. 36%; P = 0.07) in EB than that in control groups. The results of the second trial revealed that a significantly (P < 0.05) shorter estrus and earlier ovulatory events were observed in EB-treated heifers. It is concluded that the incorporation of Estradiol Benzoate to the CIDR protocol is helpful to improve the estrus signs and enhance the ovulation and the pregnancy per AI in crossbred dairy heifers.
The role of interleukin-1b and its antagonist (diacerein) in estradiol benzoate-induced endometrial hyperplasia and atypia in female rats.[Pubmed:28299811]
Fundam Clin Pharmacol. 2017 Aug;31(4):438-446.
Endometrial hyperplasia (EH) is a common gynecological condition and may progress to carcinoma. We investigated the effect of diacerein (DIA) on Estradiol Benzoate (EB)-induced EH and atypia. DIA (50 mg/kg/day) was administered orally to rats for 4 weeks, in the presence or absence of EH induced by intramuscular injection of EB (60 mug/100 g) three times per week for 4 weeks. We measured levels of serum total cholesterol, uterine tissue malondialdehyde (MDA), total nitrites (NOx ), superoxide dismutase (SOD) activity, caspase-3, interleukin-1b (IL-1b) immunoexpressions, and histopathology. Results showed that EB-induced EH and atypia manifested by significant increase in serum total cholesterol with increase in MDA and NOx levels. EB showed the typical histopathological changes of EH and atypia. In addition, there was reduction in SOD activity and decrease in caspase-3 immunoexpressions but increase in IL-1b immunoexpressions. DIA was able to reduce EB-induced pathological changes.
Changes in Expression of Connexin Isoforms in the Caudal Epididymis of Adult Sprague-Dawley Rats exposed to Estradiol Benzoate or Flutamide at the Neonatal Age.[Pubmed:27796005]
Dev Reprod. 2016 Sep;20(3):237-245.
Direct communication between neighboring cells via gap junction in tissue is important for maintenance and regulation of its physiological functions. Each epididymal region has different composition of cell types. It is well recognized that the epididymis is a steroid hormone-responsive tissue. The present study was designed to determine the effect of Estradiol Benzoate (EB) or flutamide exposured at the early postnatal age on the expression of connexin (Cx) isoforms in the caudal epididymis. The EB or flutamide was subcutaneously administrated to male Spragure Dawley rat at 7 days of age, and expressional changes of Cx isoforms in the adult corpus epididymis were determined by quantitative real-time PCR. The treatment of low-dose EB resulted in decreases of Cx30.3, Cx31.1, Cx37, and Cx45 expression but caused an increase of Cx32 expression. Exposure to high-dose EB led into expressional increases of Cx31, Cx31.1, Cx32, Cx40, and Cx43, even though a decrease of Cx37 expression was found with a high-dose EB treatment. A low-dose flutamide induced increases of Cx31, Cx31.1, Cx32, and Cx43 expression but a decrease of Cx37 expression. Expression of most Cx genes were significantly increased by a high-dose flutamide, while no expressional change of Cx26 and Cx40 was detected by a high-dose flutamide. These results indicate that expression of Cx isoforms in the caudal epididymis is altered by exposure to steroidal compounds at the prepubertal age. It is suggested that a contact with environmental exogenous materials during the early postnatal period would lead to alteration of epididymal functions at the adult.
Effects of Exposure to Estradiol Benzoate or Flutamide at the Weaning Age on Expression of Connexins in the Caudal Epididymis of Adult Rat.[Pubmed:28144639]
Dev Reprod. 2016 Dec;20(4):349-357.
The present research was chiefly designed to determine the effect of the treatment of estrogenic agonist, Estradiol Benzoate (EB), or antiandrogenic compound, flutamide (Flu), at the weaning age on the expression of connexin (Cx) isoforms in the caudal epididymis of adult male rat. Animals were subcutaneously administrated with a single shot of either EB at a low-dose (0.015 microg of EB/kg body weight (BW)) or a high-dose (1.5 microg of EB/kg BW) or Flu at a low-dose (500 microg of EB/kg BW) or a high-dose (5 mg of EB/kg BW). Expressional changes of Cx isoforms in the adult caudal epididymis were examined by quantitative real-time PCR analysis. The treatment of a low-dose EB caused significant increases of Cx30.3, Cx31, Cx32, and Cx43 transcript levels but reduction of Cx31.1, Cx37, and Cx45 expression. Exposure to a high-dose EB resulted in very close responses observed in a low-dose EB treatment, except no significant expressional change of Cx37 and a significant induction of Cx40. Expression of all Cx isoforms, except Cx45, was significantly increased by a low-dose Flu treatment. Expressional increases of all Cx isoforms were detected by a high-dose Flu treatment. The current study demonstrates that a single exposure to estrogenic or antiandrogenic compound during the early postnatal developmental period is sufficient to disrupt normal expression of Cx isoforms in the adult caudal epididymis.
